Leigh Brooks
Nurse Practitioner · Princeton, WVNPI 1003299116
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (36.8%), travel and lodging and consulting fees — rather than concentrated in one kind of arrangement. 25 manufacturers reported payments, led by Gilead at 57.3% of the total. Reporting peaked in 2023 at $25,427 and has fallen 52.5% since, to $12,081 in 2025. Among nurse practitioner clinicians in WV with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 420 payments — averaging $179.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Gilead$43K
- AbbVie$31K
- Boehringer Ingelheim$247
- Indivior Inc.$174
- Exact Sciences$129
- Lilly USA, LLC$125
- plus $772 from 19 others
What the payments were for
- Consulting fees$13,16817%
- Speaking & faculty fees$27,75237%
- Travel & lodging$25,39034%
- Food & beverage$9,13312%
- Education$150%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Gilead | 172 | $43,213 |
| AbbVie | 171 | $30,799 |
| Boehringer Ingelheim | 13 | $247 |
| Indivior Inc. | 8 | $174 |
| Exact Sciences | 6 | $129 |
| Lilly USA, LLC | 8 | $125 |
| Alkermes, Inc. | 5 | $111 |
| Braeburn Inc. | 6 | $102 |
| Dexcom, Inc. | 6 | $98 |
| Amgen | 4 | $79 |
| Novo Nordisk | 4 | $59 |
| Viiv Healthcare Company | 2 | $46 |
| Phathom Pharmaceuticals, Inc. | 1 | $39 |
| Novartis | 2 | $35 |
| AstraZeneca | 2 | $32 |
| Abbott | 1 | $22 |
| Biohaven Pharmaceuticals, Inc. | 1 | $21 |
| Shield Therapeutics Inc | 1 | $19 |
| Idorsia Pharmaceuticals US Inc | 1 | $18 |
| Hologic Sales And Service, LLC | 1 | $16 |
| GSK | 1 | $16 |
| Insulet Corporation | 1 | $15 |
| Pfizer | 1 | $15 |
| Bayer | 1 | $14 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$75,458 in reported general payments places this provider in the 95th percentile of 649 nurse practitioner providers in West Virginia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EpclusaSofosbuvir/Velpatasvir | 17 | $433,011 |
| SuboxoneBuprenorphine Hcl/Naloxone Hcl | 141 | $56,941 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 408 | $33,461 |
| SublocadeBuprenorphine | 15 | $32,482 |
| VivitrolNaltrexone Microspheres | 16 | $27,493 |
| VemlidyTenofovir Alafenamide | 13 | $21,727 |
| BrixadiBuprenorphine | 15 | $11,023 |
| EliquisApixaban | 13 | $8,586 |
| LinzessLinaclotide | 11 | $5,596 |
| Gabapentin | 115 | $1,407 |
| Buprenorphine Hcl | 14 | $515 |
| Duloxetine Hcl | 15 | $497 |
| Ondansetron OdtOndansetron | 37 | $466 |
| Clonazepam | 79 | $448 |
| Quetiapine Fumarate | 30 | $414 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GileadEpclusa, Vemlidy | $43,213 | $454,73830 claims |
| Indivior Inc.Suboxone, Sublocade | $174 | $89,423156 claims |
| Alkermes, Inc.Vivitrol | $111 | $27,49316 claims |
| Braeburn Inc.Brixadi | $102 | $11,02315 claims |
| PfizerEliquis | $15 | $8,58613 claims |
| AbbVieLinzess | $30,799 | $5,59611 claims |
| Lilly USA, LLCOlanzapine | $125 | $13516 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 649 nurse practitioner providers in West Virginia.
Other nurse practitioner in Princeton
- Melissa BoglePrinceton$6K
- Destiny HowardBeckley$35K
- Rachael RigginsBeckley$19K
- Lacy HowardWheeling$18K
- Robin BlumeBeckley$18K
- Kellie VaughtBeckley$17K
- Lisa WalkerBeckley$17K
- Rachel BrillSouth Charleston$16K
- Kelly HughartSouth Charleston$13K
- Amy HaughtSouth Charleston$12K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.